Equillium Inc (EQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EQ | BMY | AMGN | GILD | REGN |
| Company | Equillium Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6300 | 49.16 | 272.14 | 67.09 | 905.66 |
| High | 1.8200 | 49.47 | 274.48 | 67.68 | 912.74 |
| Low | 1.6300 | 48.96 | 271.05 | 67.00 | 903.83 |
| Last | 1.7200 | 48.99 | 273.00 | 66.97 | 907.32 |
| Change | +0.0700 | -0.15 | +1.09 | +0.02 | +7.16 |
| % Change | +4.24% | -0.31% | +0.40% | +0.03% | +0.80% |
| Volume | 87,845 | 8,752,349 | 2,440,487 | 4,847,013 | 323,228 |
| 20-Day Average Volume | 169,531 | 10,770,681 | 2,168,712 | 6,219,864 | 434,633 |
| Previous Close | 1.6500 | 49.14 | 271.91 | 66.95 | 900.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9538 | 50.55 | 272.01 | 69.35 | 929.17 |
| 20-Day Raw Stochastic | 19.54% | 20.99% | 47.66% | 17.44% | 20.20% |
| 20-Day Relative Strength | 44.07% | 41.99% | 49.11% | 34.27% | 39.94% |
| Weighted Alpha | +4.46 | -25.61 | +11.69 | -20.43 | +14.09 |
| Today's Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 8% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.41% since 04/16/24 | +1.65% since 04/16/24 | +3.14% since 04/16/24 | -0.03% since 04/16/24 | +1.54% since 04/16/24 |
| Low | 1.5800 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 1.8900 on 04/17/24 | 49.56 on 04/22/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -37.94% since 03/22/24 | -5.54% since 03/22/24 | -0.80% since 03/22/24 | -7.33% since 03/22/24 | -6.14% since 03/22/24 |
| Low | 1.5800 on 04/22/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 2.9000 on 03/25/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +135.85% since 01/23/24 | -2.12% since 01/23/24 | -11.60% since 01/23/24 | -15.34% since 01/23/24 | -4.89% since 01/23/24 |
| Low | 0.7205 on 01/24/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 3.2500 on 02/26/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +199.71% since 10/23/23 | -12.40% since 10/23/23 | +0.33% since 10/23/23 | -13.24% since 10/23/23 | +14.12% since 10/23/23 |
| Low | 0.4500 on 11/13/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 3.2500 on 02/26/24 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 58,171 | 99,594,944 | 145,845,984 | 83,357,904 | 98,803,360 |
| Shares Outstanding, K | 35,255 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 36,080,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -13,340,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 9,210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -2,340,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.62 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 03/25/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 23.86 |